SEC Filing Summary: Neuralstem, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Neuralstem, Inc. on April 1, 2009, reporting on events occurring on March 31, 2009. The filing serves to disclose the Company's results of operations and financial condition for the fiscal year ended December 31, 2008. The specific financial data is contained within a press release attached as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1) but are not explicitly stated in the body of this 8-K document.
Material Changes
No specific material changes or comparative financial data versus prior periods are detailed in the text of this filing. The document acts as a notification that the annual results for 2008 have been announced via a separate press release.
Guidance, Outlook, and Risks
The filing includes standard Regulation FD disclosure language, noting that the information is not deemed "filed" for liability purposes under Section 18 of the Exchange Act. No specific forward-looking guidance, management commentary, or risk factors are articulated within the text of this 8-K; such details are presumed to be in the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 31, 2009) for actual financial figures for the year ended December 31, 2008.
- Verify the discrepancy between the metadata company name ("PALISADE BIO, INC.") and the registrant name in the filing ("Neuralstem, Inc.").
- Confirm the specific revenue and cash burn rates in the attached press release to assess liquidity status.
- Check for any subsequent filings that may provide updated guidance or risk disclosures not present in this initial 8-K.